Pediatric immunization for the future. Lyme disease vaccine and beyond.
This article highlights some of the exciting new developments in pediatric immunization. Starting with the newly licensed Lyme disease vaccine, which is not yet approved for children younger than 15 years of age, the article discusses potential vaccines for severe allergy and cocaine abuse and stresses some of the new techniques in needleless vaccination, including the edible plant technology.
Lutwick
L I
LI
Department of Medicine, Veterans Affairs New York Harbor Health Care System, Brooklyn, USA. larry.lutwick@med.va.gov
Abramson
J M
JM
D000818:Animals; D002648:Child; D019970:Cocaine-Related Disorders / Q000276:immunology / Q000517:prevention & control; D005544:Forecasting; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control; D007167:Immunotherapy; D018884:Ixodes / Q000187:drug effects; D008193:Lyme Disease / Q000175:diagnosis / Q000517:prevention & control*; D030821:Plants, Genetically Modified; D014611:Vaccination / Q000639:trends*; D014765:Viral Vaccines / Q000494:pharmacology
D014765:Viral Vaccines